Status:
COMPLETED
Efficacy of TOCT and (tDCS) for Gait Improvement in Patients With Chronic Stroke
Lead Sponsor:
University Hospital of Ferrara
Conditions:
Stroke
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
Stroke is one of the major causes of disability in the Western world. Initially gait is the most affected function, 80% of patients lose this ability. Rehabilitation in stroke patients improves walki...
Detailed Description
Inclusion criteria: * Males and females subjects. Age \> 18 years, \<75 years. * Diagnosis of first ischemic stroke \> 6 months. * Mini mental State Examination (MMSE) \>24; * Functional Ambulation C...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Males and females subjects. Age \> 18 years, \<75 years.
- Diagnosis of first ischemic stroke \> 6 months.
- MMSE\>24;
- FAC higher or equal to 4
- Exclusion Criteria:
- Contraindications to tDCS: intracranial metal implants that can be stimulated, incorrectly positioned or over-heated by the electric current, presence of a history of epilepsy, frequent headaches or neck pain, implantable devices (ventriculoperitoneal shunts, pacemakers, intrathecal pumps, intracranial metal implants).
- Neurological or psychiatric pathology.
- Severe cardio-pulmonary, renal, hepatic diseases.
- Pregnancy.
Exclusion
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01883843
Start Date
May 1 2013
End Date
September 1 2014
Last Update
December 23 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ferrara University Hospital
Ferrara, Ferrara, Italy, 44124